Clinical Trials on Human Characteristics in Ireland
Total 251 results
-
Novartis VaccinesCompletedInfluenzaUnited States
-
VBI Vaccines Inc.CompletedHepatitis B VaccinesUnited States, Canada, Finland, Belgium
-
Gilead SciencesCompletedChronic Hepatitis C VirusUnited States, Puerto Rico
-
Janssen Infectious Diseases BVBACompletedHepatitis C Virus InfectionUnited States, Canada
-
LumiraDx UK LimitedRecruitingInfluenza, Human | Respiratory Syncytial Virus InfectionsUnited States
-
ModernaTX, Inc.CompletedInfluenza | SARS-CoV-2 | RSVUnited Kingdom, Australia, United States
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV Infection | Infection, Human Immunodeficiency Virus IUnited States, Canada, Puerto Rico
-
Foundation for Liver ResearchHoffmann-La RocheTerminatedChronic Hepatitis CNetherlands
-
Gilead SciencesCompletedHepatitis C Virus InfectionGermany, United States, Australia, United Kingdom, Canada, France, New Zealand
-
SeqirusCompletedInfluenza, HumanUnited States
-
Sanofi Pasteur, a Sanofi CompanyCompletedInfluenzaUnited States, Puerto Rico
-
Ology BioservicesCompleted
-
ID Biomedical Corporation, QuebecUnknown
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States, Spain, France, Canada, Portugal, Italy, Belgium
-
ViiV HealthcareTerminatedHIV Infection | Infection, Human Immunodeficiency Virus IUnited States, France, Canada, Germany, Italy, Belgium, United Kingdom, Portugal, Spain
-
Janssen R&D IrelandCompletedHuman Immunodeficiency Virus Type 1United States, France, United Kingdom, Belgium, Spain, Switzerland, Sweden, Canada, Puerto Rico, Poland
-
Hoffmann-La RocheCompletedHepatitis C, ChronicAustralia, United States, Italy, France, Puerto Rico, Taiwan, United Kingdom, Greece, Poland, Brazil, Spain
-
Protein Sciences CorporationCompleted
-
Gilead SciencesCompletedHepatitis C Virus InfectionUnited States, Puerto Rico
-
MedImmune LLCCompletedInfluenzaUnited States, United Kingdom, Belgium, Czechia, Hong Kong, Ireland, Korea, Republic of, Taiwan
-
PfizerCompletedInfluenza, HumanUnited States, Brazil, South Africa, Philippines, New Zealand, Chile, Argentina
-
Gilead SciencesCompletedHepatitis CUnited States, Puerto Rico
-
National Institute of Allergy and Infectious Diseases...TerminatedHIV Infections | Hepatitis CUnited States, Puerto Rico
-
PfizerCompletedInfluenza, HumanUnited States
-
GlaxoSmithKlineCompletedHIV Infection | Infection, Human Immunodeficiency VirusUnited States, Belgium, France, Germany, Spain, Canada, Italy, Portugal, Romania, Austria, Switzerland, Poland, Latvia, Luxembourg
-
Sanofi Pasteur, a Sanofi CompanyCompletedInfluenza | Orthomyxoviridae Infection | Myxovirus InfectionUnited States
-
Sanofi Pasteur, a Sanofi CompanyCompleted
-
Gilead SciencesCompletedHepatitis CUnited States, Australia, New Zealand, Puerto Rico
-
Hoffmann-La RocheCompletedHepatitis C, ChronicSpain, United States, Germany, Canada, Austria, France
-
GlaxoSmithKlineCompletedInfluenzaUnited States, Germany, Poland, Spain, Czechia, Bangladesh, France
-
Bristol-Myers SquibbCompletedHepatitis CFrance, United Kingdom, Spain, United States, Italy, Puerto Rico, Greece
-
Novartis VaccinesCompletedFever | InfluenzaUnited States, Australia, New Zealand, Philippines, Thailand
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency Virus IUnited States, Spain, Germany, Australia, Canada, Belgium, Denmark, Netherlands, United Kingdom, France, Italy, Romania
-
FibroGenTerminatedLiver Fibrosis Due to Chronic Hepatitis B InfectionHong Kong, Thailand
-
AbbVieRecruitingHuman Immuno-deficiency Virus (HIV) DiseaseUnited States, Puerto Rico, Japan, Spain, Germany, Canada, Belgium, France, Poland, South Africa, Italy
-
SeqirusActive, not recruitingInfluenza, HumanPhilippines, United States, Germany, Pakistan, Canada, Estonia, Denmark, United Kingdom
-
Hoffmann-La RocheCompletedHepatitis C, ChronicUnited States, Canada, Slovakia, Poland, New Zealand, France, Australia
-
ViiV HealthcareGlaxoSmithKline; PPDCompletedHIV Infections | Infection, Human Immunodeficiency VirusTaiwan, France, Germany, Belgium, United States, Canada, Netherlands, Spain, Korea, Republic of, Italy, Australia, United Kingdom, Russian Federation, Portugal, Argentina, South Africa, Romania, Mexico
-
MDVI, LLCCompletedInfluenzaUnited States, Australia, Chile, New Zealand, Paraguay, Peru, South Africa
-
Bristol-Myers SquibbCompletedHepatitis CUnited States, Australia, Canada, France, Puerto Rico
-
Sanofi Pasteur, a Sanofi CompanyCompletedInfluenza | Myxovirus Infection | Orthomyxovirus InfectionUnited States
-
Hoffmann-La RocheCompletedInfluenzaItaly, United States, Spain, Hungary, France, Lithuania, Romania, Poland, Denmark
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedHIV Infections | Infection, Human Immunodeficiency VirusUnited States, France, Netherlands, Spain, Taiwan, Australia, Belgium, Russian Federation, Canada, United Kingdom, Mexico, Italy, South Africa, Romania, Argentina, Hungary, Poland, Chile, Greece, Brazil
-
National Institute of Allergy and Infectious Diseases...CompletedHIV Infection | Hepatitis C InfectionUnited States, Puerto Rico
-
ModernaTX, Inc.CompletedSeasonal InfluenzaSpain, United States, Denmark, Poland, United Kingdom, Germany, Canada, Taiwan, Bulgaria, Netherlands, Estonia
-
Vertex Pharmaceuticals IncorporatedTerminated
-
Gilead SciencesCompletedHCV InfectionUnited Kingdom, Germany, Ireland, United States, Belgium, Puerto Rico, Poland
-
ModernaTX, Inc.Active, not recruitingA Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy AdultsInfluenza | SARS-CoV-2United States
-
Hoffmann-La RocheCompletedHepatitis C, ChronicFrance, Germany, United States, New Zealand
-
GlaxoSmithKlinePPDCompletedHepatitis C, ChronicPuerto Rico, United States, Bulgaria, Germany, Belgium, France